Ann Tsukamoto of Stem Cells joined us at World Orphan Drug Congress USA 2015 to present about ‘Platform Technology for Rare CNS Diseases’
Download her presentation now to learn about:
- HuCNS-SC: First Class in Biologic
- HuCNS-SC Pre-Clinical Observations Reflected in Early Clinical Results
- Gene Modified Human Neural Stem Cells
…and much more!
Get your copy here!
To find out more about platform technology for rare CNS diseases , attend World Orphan Drug Congress USA 2016 April 20-22 in Washington DC.